Skip to main content

Advertisement

Log in

The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction

  • REVIEW
  • Published:
Journal of Cell Communication and Signaling Aims and scope

Abstract

Fetal growth restriction (FGR) increases the risk of perinatal complications and predisposes the infant to developing metabolic, cardiovascular, and neurological diseases in childhood and adulthood. The pathophysiology underlying FGR remains poorly understood and there is no specific treatment available. Biomarkers for early detection are also lacking. The insulin-like growth factor (IGF) system is an important regulator of fetal growth. IGF-I is the primary regulator of fetal growth, and fetal circulating levels of IGF-I are decreased in FGR. IGF-I activity is influenced by a family of IGF binding proteins (IGFBPs), which bind to IGF-I and decrease its bioavailability. During fetal development the predominant IGF-I binding protein in fetal circulation is IGFBP-1, which is primarily secreted by the fetal liver. IGFBP-1 binds IGF-I and thereby inhibits its bioactivity. Fetal circulating levels of IGF-I are decreased and concentrations of IGFBP-1 are increased in FGR. Phosphorylation of human IGFBP-1 at specific sites markedly increases its binding affinity for IGF-I, further limiting IGF-I bioactivity. Recent experimental evidence suggests that IGFBP-1 phosphorylation is markedly increased in the circulation of FGR fetuses suggesting an important role of IGFBP-1 phosphorylation in the regulation of fetal growth. Understanding of the significance of site-specific IGFBP-1 phosphorylation and how it is regulated to contribute to fetal growth will be an important step in designing strategies for preventing, managing, and/or treating FGR. Furthermore, IGFBP-1 hyperphosphorylation at unique sites may serve as a valuable biomarker for FGR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Abu Shehab M, Inoue S, Han VK, Gupta MB (2009) Site specific phosphorylation of insulin-like growth factor binding protein-1 (IGFBP-1) for evaluating clinical relevancy in fetal growth restriction. J Proteome Res 8:5325–5335. doi:10.1021/pr900633x

    Article  CAS  PubMed  Google Scholar 

  • Abu Shehab M, Khosravi J, Han VK, Shilton BH, Gupta MB (2010) Site-specific IGFBP-1 hyper-phosphorylation in fetal growth restriction: clinical and functional relevance. J Proteome Res 9:1873–1881. doi:10.1021/pr900987n

    Article  CAS  PubMed  Google Scholar 

  • Abu Shehab M, Iosef C, Wildgruber R, Sardana G, Gupta MB (2013) Phosphorylation of IGFBP-1 at discrete sites elicits variable effects on IGF-I receptor autophosphorylation. Endocrinology 154:1130–1143. doi:10.1210/en.2012-1962

    Article  CAS  PubMed  Google Scholar 

  • Abu Shehab M, Damerill I, Shen T, Rosario FJ, Nijland M, Nathanielsz PW, Kamat A, Jansson T, Gupta MB (2014) Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction. Endocrinology 155:1327–1339. doi:10.1210/en.2013-1759

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Ankrapp DP, Jones JI, Clemmons DR (1996) Characterization of insulin-like growth factor binding protein-1 kinases from human hepatoma cells. J Cell Biochem 60:387–399. doi:10.1002/(SICI)1097-4644(19960301)60:3<387::AID-JCB10>3.0.CO;2-I

    Article  CAS  PubMed  Google Scholar 

  • Antonow-Schlorke I, Schwab M, Cox LA, Li C, Stuchlik K, Witte OW, Nathanielsz PW, McDonald TJ (2011) Vulnerability of the fetal primate brain to moderate reduction in maternal global nutrient availability. Proc Natl Acad Sci U S A 108:3011–3016. doi:10.1073/pnas.1009838108

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Averous J, Maurin AC, Bruhat A, Jousse C, Arliguie C, Fafournoux P (2005) Induction of IGFBP-1 expression by amino acid deprivation of HepG2 human hepatoma cells involves both a transcriptional activation and an mRNA stabilization due to its 3′UTR. FEBS Lett 579:2609–2614. doi:10.1016/j.febslet.2005.03.077

    Article  CAS  PubMed  Google Scholar 

  • Baker J, Liu JP, Robertson EJ, Efstratiadis A (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73–82

    Article  CAS  PubMed  Google Scholar 

  • Barker DJ (2006) Adult consequences of fetal growth restriction. Clin Obstet Gynecol 49:270–283

    Article  PubMed  Google Scholar 

  • Baschat AA, Hecher K (2004) Fetal growth restriction due to placental disease. Semin Perinatol 28:67–80

    Article  PubMed  Google Scholar 

  • Baxter RC (2000) Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278:E967–76

    CAS  PubMed  Google Scholar 

  • Ben Lagha N, Seurin D, Le Bouc Y, Binoux M, Berdal A, Menuelle P, Babajko S (2006) Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: study on IGFBP-1 overexpressing transgenic mice. Endocrinology 147:4730–4737. doi:10.1210/en.2006-0171

    Article  CAS  PubMed  Google Scholar 

  • Bhatia S, Faessen GH, Carland G, Balise RL, Gargosky SE, Druzin M, El-Sayed Y, Wilson DM, Giudice LC (2002) A longitudinal analysis of maternal serum insulin-like growth factor I (IGF-I) and total and nonphosphorylated IGF-binding protein-1 in human pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Metab 87:1864–1870

    Article  CAS  PubMed  Google Scholar 

  • Bohana-Kashtan O, Pinna LA, Fishelson Z (2005) Extracellular phosphorylation of C9 by protein kinase CK2 regulates complement-mediated lysis. Eur J Immunol 35:1939–1948. doi:10.1002/eji.200425716

    Article  CAS  PubMed  Google Scholar 

  • Buckway CK, Wilson EM, Ahlsen M, Bang P, Oh Y, Rosenfeld RG (2001) Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding. J Clin Endocrinol Metab 86:4943–4950

    Article  CAS  PubMed  Google Scholar 

  • Busby WH Jr, Klapper DG, Clemmons DR (1988) Purification of a 31,000-dalton insulin-like growth factor binding protein from human amniotic fluid. Isolation of two forms with different biologic actions. J Biol Chem 263:14203–14210

    CAS  PubMed  Google Scholar 

  • Chard T (1994) Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul 4:91–100

    CAS  PubMed  Google Scholar 

  • Chelius D, Baldwin MA, Lu X, Spencer EM (2001) Expression, purification and characterization of the structure and disulfide linkages of insulin-like growth factor binding protein-4. J Endocrinol 168:283–296

    Article  CAS  PubMed  Google Scholar 

  • Cianfarani S, Germani D, Rossi P, Rossi L, Germani A, Ossicini C, Zuppa A, Argiro G, Holly JM, Branca F (1998) Intrauterine growth retardation: evidence for the activation of the insulin-like growth factor (IGF)-related growth-promoting machinery and the presence of a cation-independent IGF binding protein-3 proteolytic activity by two months of life. Pediatr Res 44:374–380

    Article  CAS  PubMed  Google Scholar 

  • Clemmons DR (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8:45–62

    Article  CAS  PubMed  Google Scholar 

  • Conover CA, Lee PD, Riggs BL, Powell DR (1996) Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid. Endocrinology 137:3295–3301

    CAS  PubMed  Google Scholar 

  • Coverley JA, Baxter RC (1997) Phosphorylation of insulin-like growth factor binding proteins. Mol Cell Endocrinol 128:1–5

    Article  CAS  PubMed  Google Scholar 

  • Dolcini L, Sala A, Campagnoli M, Labo S, Valli M, Visai L, Minchiotti L, Monaco HL, Galliano M (2009) Identification of the amniotic fluid insulin-like growth factor binding protein-1 phosphorylation sites and propensity to proteolysis of the isoforms. FEBS J 276:6033–6046. doi:10.1111/j.1742-4658.2009.07318.x

    Article  CAS  PubMed  Google Scholar 

  • Eghbali-Fatourechi G, Conover CA, Sieck GC, Gores GJ, Fitzpatrick LA (1994) Secretion of insulin-like growth factor binding protein-1 from individual hepatocytes. Res Commun Mol Pathol Pharmacol 85:243–259

    CAS  PubMed  Google Scholar 

  • Fang Q, Wang YX, Zhou Y (2004) Insulin-like growth factor binding protein 1 and human embryonic development during 6–10 gestational weeks. Chin Med J (Engl) 117:488–491

    CAS  Google Scholar 

  • Faust M, Jung M, Gunther J, Zimmermann R, Montenarh M (2001) Localization of individual subunits of protein kinase CK2 to the endoplasmic reticulum and to the Golgi apparatus. Mol Cell Biochem 227:73–80

    Article  CAS  PubMed  Google Scholar 

  • Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824–854

    Article  CAS  PubMed  Google Scholar 

  • Foster KG, Fingar DC (2010) Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J Biol Chem 285:14071–14077. doi:10.1074/jbc.R109.094003

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Fowler D, Albaiges G, Lees C, Jones J, Nicolaides K, Miell J (1999) The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by doppler ultrasound. Hum Reprod 14:2881–2885

    Article  CAS  PubMed  Google Scholar 

  • Frost RA, Tseng L (1991) Insulin-like growth factor-binding protein-1 is phosphorylated by cultured human endometrial stromal cells and multiple protein kinases in vitro. J Biol Chem 266:18082–18088

    CAS  PubMed  Google Scholar 

  • Geerts LT, Brand EJ, Theron GB (1996) Routine obstetric ultrasound examinations in South Africa: cost and effect on perinatal outcome–a prospective randomised controlled trial. Br J Obstet Gynaecol 103:501–507

    Article  CAS  PubMed  Google Scholar 

  • Gibson JM, Westwood M, Lauszus FF, Klebe JG, Flyvbjerg A, White A (1999) Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects. Diabetes 48:321–326

    Article  CAS  PubMed  Google Scholar 

  • Gibson JM, Aplin JD, White A, Westwood M (2001) Regulation of IGF bioavailability in pregnancy. Mol Hum Reprod 7:79–87

    Article  CAS  PubMed  Google Scholar 

  • Giudice LC (2002) Maternal-fetal conflict–lessons from a transgene. J Clin Invest 110:307–309

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, Hintz RL, Rosenfeld RG (1995) Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 80:1548–1555

    CAS  PubMed  Google Scholar 

  • Graham ME, Kilby DM, Firth SM, Robinson PJ, Baxter RC (2007) The in vivo phosphorylation and glycosylation of human insulin-like growth factor-binding protein-5. Mol Cell Proteomics 6:1392–1405. doi:10.1074/mcp. M700027-MCP200

    Article  CAS  PubMed  Google Scholar 

  • Han VK, Bassett N, Walton J, Challis JR (1996a) The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab 81:2680–2693. doi:10.1210/jcem.81.7.8675597

    CAS  PubMed  Google Scholar 

  • Han VK, Matsell DG, Delhanty PJ, Hill DJ, Shimasaki S, Nygard K (1996b) IGF-binding protein mRNAs in the human fetus: tissue and cellular distribution of developmental expression. Horm Res 45:160–166

    Article  CAS  PubMed  Google Scholar 

  • Hills FA, English J, Chard T (1996) Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol 148:303–309

    Article  CAS  PubMed  Google Scholar 

  • Holmes R, Montemagno R, Jones J, Preece M, Rodeck C, Soothill P (1997) Fetal and maternal plasma insulin-like growth factors and binding proteins in pregnancies with appropriate or retarded fetal growth. Early Hum Dev 49:7–17

    Article  CAS  PubMed  Google Scholar 

  • Imai Y, Moralez A, Andag U, Clarke JB, Busby WH Jr, Clemmons DR (2000) Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and −5 markedly reduce IGF-I binding and alter their biologic actions. J Biol Chem 275:18188–18194. doi:10.1074/jbc.M000070200

    Article  CAS  PubMed  Google Scholar 

  • Iwashita M, Sakai K, Kudo Y, Takeda Y (1998) Phosphoisoforms of insulin-like growth factor binding protein-1 in appropriate-for-gestational-age and small-for-gestational-age fetuses. Growth Horm IGF Res 8:487–493

    Article  CAS  PubMed  Google Scholar 

  • Janeczko M, Maslyk M, Szyszka R, Baier A (2011) Interactions between subunits of protein kinase CK2 and their protein substrates influences its sensitivity to specific inhibitors. Mol Cell Biochem 356:121–126. doi:10.1007/s11010-011-0951-x

    Article  CAS  PubMed  Google Scholar 

  • Jansson T, Scholtbach V, Powell TL (1998) Placental transport of leucine and lysine is reduced in intrauterine growth restriction. Pediatr Res 44:532–537

    Article  CAS  PubMed  Google Scholar 

  • Jones JI, D’Ercole AJ, Camacho-Hubner C, Clemmons DR (1991) Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci U S A 88:7481–7485

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Jones JI, Busby WH Jr, Wright G, Smith CE, Kimack NM, Clemmons DR (1993a) Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101. J Biol Chem 268(2):1125–31

    CAS  PubMed  Google Scholar 

  • Jones JI, Busby WH Jr, Wright G, Clemmons DR (1993b) Human IGFBP-1 is phosphorylated on 3 serine residues: effects of site-directed mutagenesis of the major phosphoserine. Growth Regul 3:37–40

    CAS  PubMed  Google Scholar 

  • Kabir-Salmani M, Shimizu Y, Sakai K, Iwashita M (2005) Posttranslational modifications of decidual IGFBP-1 by steroid hormones in vitro. Mol Hum Reprod 11:667–671. doi:10.1093/molehr/gah222

    Article  CAS  PubMed  Google Scholar 

  • Kajimura S, Aida K, Duan C (2006) Understanding hypoxia-induced gene expression in early development: in vitro and in vivo analysis of hypoxia-inducible factor 1-regulated zebra fish insulin-like growth factor binding protein 1 gene expression. Mol Cell Biol 26:1142–1155. doi:10.1128/MCB.26.3.1142-1155.2006

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kelly JH, Darlington GJ (1989) Modulation of the liver specific phenotype in the human hepatoblastoma line Hep G2. In Vitro Cell Dev Biol 25:217–222

    Article  CAS  PubMed  Google Scholar 

  • Khosravi J, Krishna RG, Bodani U, Diamandi A, Khaja N, Kalra B, Kumar A (2007) Immunoassay of serine-phosphorylated isoform of insulin-like growth factor (IGF) binding protein (IGFBP)-1. Clin Biochem 40:86–93. doi:10.1016/j.clinbiochem.2006.07.004

    Article  CAS  PubMed  Google Scholar 

  • Koistinen R, Itkonen O, Selenius P, Seppala M (1990) Insulin-like growth factor-binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates their DNA synthesis. Biochem Biophys Res Commun 173:408–415

    Article  CAS  PubMed  Google Scholar 

  • Koistinen R, Angervo M, Leinonen P, Seppala M (1993a) Phosphorylation of insulin-like growth factor-binding protein-1 from different sources. Growth Regul 3:34–37

    CAS  PubMed  Google Scholar 

  • Koistinen R, Angervo M, Leinonen P, Hakala T, Seppala M (1993b) Phosphorylation of insulin-like growth factor-binding protein-1 increases in human amniotic fluid and decidua from early to late pregnancy. Clin Chim Acta 215:189–199

    Article  CAS  PubMed  Google Scholar 

  • Koumenis C, Wouters BG (2006) “Translating” tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol Cancer Res 4:423–436. doi:10.1158/1541-7786.MCR-06-0150

    Article  CAS  PubMed  Google Scholar 

  • Kwek K, Khi C, Ting HS, Yeo GS (2004) Evaluation of a bedside test for phosphorylated insulin-like growth factor binding protein-1 in preterm labour. Ann Acad Med Singap 33:780–783

    CAS  PubMed  Google Scholar 

  • Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122:3589–3594. doi:10.1242/jcs.051011

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M (1991) Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 29:219–225. doi:10.1203/00006450-199103000-00001

    Article  CAS  PubMed  Google Scholar 

  • Lee PD, Conover CA, Powell DR (1993) Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 204:4–29

    Article  CAS  PubMed  Google Scholar 

  • Li C, Schlabritz-Loutsevitch NE, Hubbard GB, Han V, Nygard K, Cox LA, McDonald TJ, Nathanielsz PW (2009) Effects of maternal global nutrient restriction on fetal baboon hepatic insulin-like growth factor system genes and gene products. Endocrinology 150:4634–4642. doi:10.1210/en.2008-1648

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Li C, Shu ZJ, Lee S, Gupta MB, Jansson T, Nathanielsz PW, Kamat A (2013) Effects of maternal nutrient restriction, intrauterine growth restriction, and glucocorticoid exposure on phosphoenolpyruvate carboxykinase-1 expression in fetal baboon hepatocytes in vitro. J Med Primatol 42:211–219. doi:10.1111/jmp.12048

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lindqvist PG, Molin J (2005) Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol 25:258–264. doi:10.1002/uog.1806

    Article  CAS  PubMed  Google Scholar 

  • Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59–72

    CAS  PubMed  Google Scholar 

  • Liu Z, Panousis C, Smyth FE, Murphy R, Wirth V, Cartwright G, Johns TG, Scott AM (2003) Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses. Hybrid Hybridomics 22:219–228. doi:10.1089/153685903322328947

    Article  CAS  PubMed  Google Scholar 

  • Loukovaara M, Leinonen P, Teramo K, Nurminen E, Andersson S, Rutanen EM (2005) Effect of maternal diabetes on phosphorylation of insulin-like growth factor binding protein-1 in cord serum. Diabet Med 22:434–439. doi:10.1111/j.1464-5491.2005.01430.x

    Article  CAS  PubMed  Google Scholar 

  • Martina NA, Kim E, Chitkara U, Wathen NC, Chard T, Giudice LC (1997) Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab 82:1894–1898

    CAS  PubMed  Google Scholar 

  • Maruyama M, Matsunaga T, Harada E, Ohmori S (2007) Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells. Biol Pharm Bull 30:2091–2097

    Article  CAS  PubMed  Google Scholar 

  • Murphy VE, Smith R, Giles WB, Clifton VL (2006) Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 27:141–169. doi:10.1210/er.2005-0011

    Article  PubMed  Google Scholar 

  • Neumann GM, Bach LA (1999) The N-terminal disulfide linkages of human insulin-like growth factor-binding protein-6 (hIGFBP-6) and hIGFBP-1 are different as determined by mass spectrometry. J Biol Chem 274:14587–14594

    Article  CAS  PubMed  Google Scholar 

  • Nissum M, Abu Shehab M, Sukop U, Khosravi JM, Wildgruber R, Eckerskorn C, Han VK, Gupta MB (2009) Functional and complementary phosphorylation state attributes of human insulin-like growth factor-binding protein-1 (IGFBP-1) isoforms resolved by free flow electrophoresis. Mol Cell Proteomics 8:1424–1435. doi:10.1074/mcp. M800571-MCP200

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Olausson H, Lof M, Brismar K, Forsum E, Sohlstrom A (2010) Maternal serum concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-1 before and during pregnancy in relation to maternal body weight and composition and infant birth weight. Br J Nutr 104:842–848. doi:10.1017/S0007114510001224

    Article  CAS  PubMed  Google Scholar 

  • Olsten ME, Litchfield DW (2004) Order or chaos? An evaluation of the regulation of protein kinase CK2. Biochem Cell Biol 82:681–693. doi:10.1139/o04-116

    Article  CAS  PubMed  Google Scholar 

  • Ong K, Kratzsch J, Kiess W, Costello M, Scott C, Dunger D (2000) Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Clin Endocrinol Metab 85:4266–4269

    CAS  PubMed  Google Scholar 

  • Orlando-Mathur CE, Bechberger JF, Goldberg GS, Naus CC, Kidder GM, Kennedy TG (1996) Rat endometrial stromal cells express the gap junction genes connexins 26 and 43 and form functional gap junctions during in vitro decidualization. Biol Reprod 54:905–913

    Article  CAS  PubMed  Google Scholar 

  • Orlowski CC, Ooi GT, Rechler MM (1990) Dexamethasone stimulates transcription of the insulin-like growth factor-binding protein-1 gene in H4-II-E rat hepatoma cells. Mol Endocrinol 4:1592–1599

    Article  CAS  PubMed  Google Scholar 

  • Patel S, Lochhead PA, Rena G, Fumagalli S, Pende M, Kozma SC, Thomas G, Sutherland C (2002) Insulin regulation of insulin-like growth factor-binding protein-1 gene expression is dependent on the mammalian target of rapamycin, but independent of ribosomal S6 kinase activity. J Biol Chem 277:9889–9895. doi:10.1074/jbc.M109870200

    Article  CAS  PubMed  Google Scholar 

  • Popovici RM, Lu M, Bhatia S, Faessen GH, Giaccia AJ, Giudice LC (2001) Hypoxia regulates insulin-like growth factor-binding protein 1 in human fetal hepatocytes in primary culture: suggestive molecular mechanisms for in utero fetal growth restriction caused by uteroplacental insufficiency. J Clin Endocrinol Metab 86:2653–2659

    CAS  PubMed  Google Scholar 

  • Powell D, Lee PD, DePaolis LA, Morris SL, Suwanichkul A (1993) Dexamethasone stimulates expression of insulin-like growth factor binding protein-1 in HEP G2 human hepatoma cells. Growth Regul 3:11–13

    CAS  PubMed  Google Scholar 

  • Qiu C, Vadachkoria S, Meryman L, Frederick IO, Williams MA (2005) Maternal plasma concentrations of IGF-1, IGFBP-1, and C-peptide in early pregnancy and subsequent risk of gestational diabetes mellitus. Am J Obstet Gynecol 193:1691–1697. doi:10.1016/j.ajog.2005.04.015

    Article  CAS  PubMed  Google Scholar 

  • Sakai K, D’Ercole AJ, Murphy LJ, Clemmons DR (2001) Physiological differences in insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation in IGFBP-1 transgenic mice. Diabetes 50:32–38

    Article  CAS  PubMed  Google Scholar 

  • Schedlich LJ, Nilsen T, John AP, Jans DA, Baxter RC (2003) Phosphorylation of insulin-like growth factor binding protein-3 by deoxyribonucleic acid-dependent protein kinase reduces ligand binding and enhances nuclear accumulation. Endocrinology 144:1984–1993. doi:10.1210/en.2002-220798

    Article  CAS  PubMed  Google Scholar 

  • Schlabritz-Loutsevitch NE, Dudley CJ, Gomez JJ, Nevill CH, Smith BK, Jenkins SL, McDonald TJ, Bartlett TQ, Nathanielsz PW, Nijland MJ (2007) Metabolic adjustments to moderate maternal nutrient restriction. Br J Nutr 98:276–284. doi:10.1017/S0007114507700727

    Article  CAS  PubMed  Google Scholar 

  • Seferovic MD, Ali R, Kamei H, Liu S, Khosravi JM, Nazarian S, Han VK, Duan C, Gupta MB (2009) Hypoxia and leucine deprivation induce human insulin-like growth factor binding protein-1 hyperphosphorylation and increase its biological activity. Endocrinology 150:220–231. doi:10.1210/en.2008-0657

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sengupta S, Peterson TR, Sabatini DM (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40:310–322. doi:10.1016/j.molcel.2010.09.026

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH (2012) Maternal serum placental growth hormone at 11–13 weeks’ gestation in pregnancies delivering small for gestational age neonates. J Matern Fetal Neonatal Med 25:1796–1799. doi:10.3109/14767058.2012.663834

    Article  CAS  PubMed  Google Scholar 

  • Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA (2006) Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc Natl Acad Sci U S A 103:13028–13033. doi:10.1073/pnas.0605652103

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Siwanowicz I, Popowicz GM, Wisniewska M, Huber R, Kuenkele KP, Lang K, Engh RA, Holak TA (2005) Structural basis for the regulation of insulin-like growth factors by IGF binding proteins. Structure 13:155–167. doi:10.1016/j.str.2004.11.009

    Article  CAS  PubMed  Google Scholar 

  • Solomon AL, Siddals KW, Baker PN, Gibson JM, Aplin JD, Westwood M (2014) Placental alkaline phosphatase de-phosphorylates insulin-like growth factor (IGF)-binding protein-1. Placenta 35:520–522. doi:10.1016/j. placenta .2014.04.014

    Article  CAS  PubMed  Google Scholar 

  • St-Denis NA, Litchfield DW (2009) Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival. Cell Mol Life Sci 66:1817–1829. doi:10.1007/s00018-009-9150-2

    Article  CAS  PubMed  Google Scholar 

  • Street ME, Seghini P, Fieni S, Ziveri MA, Volta C, Martorana D, Viani I, Gramellini D, Bernasconi S (2006) Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol 155:567–574. doi:10.1530/eje.1.02251

    Article  CAS  PubMed  Google Scholar 

  • Tapanainen PJ, Bang P, Wilson K, Unterman TG, Vreman HJ, Rosenfeld RG (1994) Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr Res 36:152–158. doi:10.1203/00006450-199408000-00004

    Article  CAS  PubMed  Google Scholar 

  • Tapanainen PJ, Bang P, Muller HL, Wilson K, Rosenfeld RG (1997) Hypoxia-induced changes in insulin-like growth factors and their binding proteins in pregnant rats. Horm Res 48:227–234

    Article  CAS  PubMed  Google Scholar 

  • Tazuke SI, Mazure NM, Sugawara J, Carland G, Faessen GH, Suen LF, Irwin JC, Powell DR, Giaccia AJ, Giudice LC (1998) Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: a possible model for IGFBP-1 expression in fetal hypoxia. Proc Natl Acad Sci U S A 95:10188–10193

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Temporini C, Dolcini L, Abee A, Calleri E, Galliano M, Caccialanza G, Massolini G (2008) Development of an integrated chromatographic system for on-line digestion and characterization of phosphorylated proteins. J Chromatogr A 1183:65–75. doi:10.1016/j.chroma.2007.12.091

    Article  CAS  PubMed  Google Scholar 

  • Tisi DK, Liu XJ, Wykes LJ, Skinner CD, Koski KG (2005) Insulin-like growth factor II and binding proteins 1 and 3 from second trimester human amniotic fluid are associated with infant birth weight. J Nutr 135:1667–1672

    CAS  PubMed  Google Scholar 

  • Wang HS, Lim J, English J, Irvine L, Chard T (1991) The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J Endocrinol 129:459–464

    Article  CAS  PubMed  Google Scholar 

  • Watson CS, Bialek P, Anzo M, Khosravi J, Yee SP, Han VK (2006) Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction. Endocrinology 147:1175–1186. doi:10.1210/en.2005-0606

    Article  CAS  PubMed  Google Scholar 

  • Weber MM, Spottl G, Gossl C, Engelhardt D (1999) Characterization of human insulin-like growth factor-binding proteins by two-dimensional polyacrylamide gel electrophoresis and Western ligand blot analysis. J Clin Endocrinol Metab 84:1679–1684

    CAS  PubMed  Google Scholar 

  • Westwood M (1999) Role of insulin-like growth factor binding protein 1 in human pregnancy. Rev Reprod 4:160–167

    Article  CAS  PubMed  Google Scholar 

  • Westwood M, Gibson JM, Davies AJ, Young RJ, White A (1994) The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 79:1735–1741

    CAS  PubMed  Google Scholar 

  • Westwood M, Gibson JM, Williams AC, Clayton PE, Hamberg O, Flyvbjerg A, White A (1995) Hormonal regulation of circulating insulin-like growth factor-binding protein-1 phosphorylation status. J Clin Endocrinol Metab 80:3520–3527

    CAS  PubMed  Google Scholar 

  • Westwood M, Gibson JM, White A (1997) Purification and characterization of the insulin-like growth factor-binding protein-1 phosphoform found in normal plasma. Endocrinology 138:1130–1136

    CAS  PubMed  Google Scholar 

  • Wilkening S, Stahl F, Bader A (2003) Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos 31:1035–1042. doi:10.1124/dmd.31.8.1035

    Article  CAS  PubMed  Google Scholar 

  • Woodall SM, Breier BH, Johnston BM, Gluckman PD (1996) A model of intrauterine growth retardation caused by chronic maternal undernutrition in the rat: effects on the somatotrophic axis and postnatal growth. J Endocrinol 150:231–242

    Article  CAS  PubMed  Google Scholar 

  • Yan X, Forbes BE, McNeil KA, Baxter RC, Firth SM (2004) Role of N- and C-terminal residues of insulin-like growth factor (IGF)-binding protein-3 in regulating IGF complex formation and receptor activation. J Biol Chem 279:53232–53240. doi:10.1074/jbc.M409345200

    Article  CAS  PubMed  Google Scholar 

  • Yu J, Iwashita M, Kudo Y, Takeda Y (1998) Phosphorylated insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) inhibits while non-phosphorylated IGFBP-1 stimulates IGF-I-induced amino acid uptake by cultured trophoblast cells. Growth Horm IGF Res 8:65–70

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants from the National Institute of Health (HD078313 and HD071306), the Lawson and the Children’s Health Research Institutes.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Madhulika B. Gupta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gupta, M.B. The role and regulation of IGFBP-1 phosphorylation in fetal growth restriction. J. Cell Commun. Signal. 9, 111–123 (2015). https://doi.org/10.1007/s12079-015-0266-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12079-015-0266-x

Keywords

Navigation